|
Michael D. Coffee is chief business officer for Avigen. Prior to joining Avigen Mr. Coffee co-founded the Alekta Group LLC to provide a comprehensive range of pharmaceutical development consulting services to emerging pharmaceutical companies. Previously Mr. Coffee was president and chief operating officer of Amarin Corporation PLC and Amarin Pharmaceuticals Inc. Prior to that Mr. Coffee held the position of president and chief operating officer of Elan Pharmaceuticals North America. Formerly he was president and chief operating officer of Athena Neurosciences Inc. and prior to that was executive vice president of commercial operations for Athena. Mr. Coffee received a BS in biology from Siena College and is a board member of Salu Inc. | 